| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-11-21 | ORVILLE JACOB A EVP, GM, Screening | Sale | -5,000 | -17.71%23,237 | $75.00 | $375,000 | View SEC filing | |
| 2025-11-21 | Herriott James SVP, General Counsel & Sec | Sale | -1,000 | -7.95%11,585 | $70.00 | $70,000 | View SEC filing | |
| 2025-11-06 | Herriott James SVP, General Counsel & Sec | Sale | -1,500 | -10.65%12,585 | $70.08 | $105,120 | View SEC filing | |
| 2025-11-06 | Baranick Brian EVP, GM, Precision Oncology | Sale | -2,858 | -11.33%22,368 | $70.08 | $200,289 | View SEC filing | |
| 2025-10-27 | Zanotti Katherine S Director | Sale | -12,000 | -16.49%60,759 | $65.00 | $780,000 | View SEC filing | |
| 2025-10-10 | Herriott James SVP, General Counsel & Sec | Sale | -1,500 | -9.62%14,085 | $60.00 | $90,000 | View SEC filing | |
| 2025-10-10 | Doyle James Edward Director | Sale | -2,000 | -3.34%57,962 | $60.00 | $120,000 | View SEC filing | |
| 2025-08-14 | Doyle James Edward Director | Sale | -1,485 | -2.42%59,962 | $42.02 | $62,400 | View SEC filing | |
| 2025-06-16 | Zanotti Katherine S Director | Sale | -3,207 | -4.22%72,759 | $53.20 | $170,612 | View SEC filing | |
| 2024-11-13 | Conroy Kevin T President and CEO | Purchase | +19,500 | +1.85%1,074,191 | $51.35 | $1,001,325 | View SEC filing | |
| 2024-10-09 | Baranick Brian EVP, GM, Precision Oncology | Sale | -929 | -6.79%12,758 | $70.00 | $65,030 | View SEC filing | |
| 2024-09-19 | Baranick Brian EVP, GM, Precision Oncology | Sale | -929 | -6.36%13,687 | $70.00 | $65,030 | View SEC filing | |
| 2024-05-02 | COWARD D SCOTT Director | Sale | -67 | -0.15%44,644 | $60.15 | $4,030 | View SEC filing | |
| 2024-05-02 | Cunningham Everett Chief Commercial Officer | Sale | -136 | -0.29%47,042 | $60.15 | $8,180 | View SEC filing | |
| 2024-05-02 | Herriott James SVP, General Counsel & Sec | Sale | -30 | -0.30%9,866 | $60.15 | $1,805 | View SEC filing | |
| 2024-05-02 | Conroy Kevin T President and CEO | Sale | -1,155 | -0.10%1,156,191 | $60.15 | $69,473 | View SEC filing | |
| 2024-05-02 | ORVILLE JACOB A General Manager, Screening | Sale | -102 | -0.70%14,440 | $60.15 | $6,135 | View SEC filing | |
| 2024-05-02 | Baranick Brian EVP, GM., Precision Oncology | Sale | -110 | -0.82%13,279 | $60.15 | $6,617 | View SEC filing | |
| 2024-05-02 | Condella Sarah EVP, Human Resources | Sale | -102 | -0.14%72,611 | $60.15 | $6,135 | View SEC filing | |
| 2024-05-02 | Elliott Jeffrey Thomas Chief Financial Officer | Sale | -136 | -1.14%11,795 | $60.15 | $8,180 | View SEC filing | |
| 2024-04-03 | Condella Sarah EVP, Human Resources | Sale | -2,000 | -2.71%71,787 | $70.00 | $140,000 | View SEC filing | |
| 2024-04-03 | Baranick Brian EVP, GM., Precision Oncology | Sale | -924 | -6.56%13,171 | $79.43 | $73,393 | View SEC filing | |
| 2024-04-01 | Condella Sarah EVP, Human Resources | Sale | -2,000 | -2.64%73,787 | $70.00 | $140,000 | View SEC filing | |
| 2024-03-04 | ORVILLE JACOB A General Manager, Screening | Sale | -2,154 | -13.07%14,324 | $59.32 | $127,775 | View SEC filing | |
| 2024-03-04 | LEVANGIE DANIEL J Director | Sale | -5,000 | -17.87%22,975 | $57.50 | $287,500 | View SEC filing |
1-25 of 370
